Since our founding in 2012, we have continually updated our technologies to keep pace with advances in genetic research and screening techniques. Our screens rely on next-generation sequencing that delivers over 99% accuracy clinical detection rates for most conditions. This powerful technique looks at entire coding regions of genes rather than the abbreviated sequencing or genotyping techniques used by other genetic screening companies. And because we detect genetic pathogenic variants that can be missed by abbreviated screening technologies, you can count on your NxGen MDx screening results to give you a highly accurate, comprehensive assessment of your true risk and ultimately, better outcomes for you and your family.